Immunotherapeutic approaches to treat cancer: Prospects and challenges

Thumbnail Image

Date

2021-05

Authors

Fred, Namanda Rogers

Journal Title

Journal ISSN

Volume Title

Publisher

BRAC University

Abstract

This review examines and summarizes major novel immunotherapeutic modalities used in cancer immunotherapy that are currently approved or in clinical trials, as well as their therapeutic potential, side effects, challenges, and future directions The aim of this study was to show different immunotherapeutic modalities used to treat cancer. The mechanism of action of the immune system to combat cancer e.g. Adoptive T cell transfer therapy (TIL, TCR, CAR T Cells), Immune checkpoint inhibitors, monoclonal antibodies cancer vaccines, cytokines and enzyme therapeutic. Second, the study aims to create awareness and provide hope to cancer patients as well as to academics interested in learning more about immunotherapy. Immunotherapy has shown great potential and promise in the treatment of a variety of cancers like solid tumors and hematologic malignancies. Finally, it discusses immunotherapy treatment prospects in the future, including combination therapy.

Description

Cataloged from PDF version of thesis report.
Includes bibliographical references (pages 74-87).
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Keywords

Immunotherapy, TIL, TCR, CAR T Cells, Monoclonal antibodies, Checkpoint inhibitors

Citation

Endorsement

Review

Supplemented By

Referenced By